IGI Logo
Toggle Navigation
News
Hindi
Hindi News
Top News
Screeners
Stocks
Stocks Screener
Stock
News
Stock Market Home Page
Stock News
Industry News
Economy News
Stock on the move
Expert Views
Research Reports
Company Result
Comp Info And Fundamentals
Company Profile
Equity
Financial Ratios
Results
Balance Sheet
Profit And Loss
Cash Flow
Share Holding
Derivatives (F&O)
Get Quotes
Market Watch
Top Gainers
Top Losers
Top Traded Quantity
Top Traded Value
Most Active Puts
Derivatives (F&O)
Most Active Calls
Put Call Ratio
Highest In Premium
Daily Settlement Price
FII and DII Statistics
Open Interest: Highest In OI
Open Interest: Lowest In OI
Derivatives (F&O)
Open Interest: Increase in OI Increase in Price
Open Interest: Decline in OI Decrease in Price
Derivative Watch
Derivatives Dashboard
Historical Data
List of Underlyings & Underlying Info
Derivative Watch
Derivatives Dashboard
Market Reports
Top Gainers
Top Losers
Monthly High/Low
52 Week High
52 Week Low
Market Cap Gainers
Market Cap Losers
PE Ratio
>More Market Reports
IPO
News
IPO News
IPO Issue Reports
Commodity
Commodity Market
Commodity Home Page
Commodity News
Commodity Reports
Market Details
Get Quotes
Top Gainers
Top Losers
Top Volume
Top Value
Top Gainers Spot Market
Top Losers Spot Market
High & Low
Commodity Indices
Technical Analysis
Advance Declines
High & Low
Highest In OI
Lowest OI
Increase In Open Interest(%)
Descrease In Open Interest(%)
Currency
News
Currency News
Economy News
Currency Reports
Mutual Fund
News
Mutual Fund Home Page
Mutual Fund News
Mutual Fund Details
Mutual Fund Home Page
Compare Scheme
Scheme Profile
Mutual fund Investment
Mutual Fund Share Holding
Mutual Fund Statistics
Mutual fund Gainers
Mutual fund Losers
Biggest Schemes
Best Performers
Latest Dividend Details
Tools
Multi Scheme Comparison Tool
Dividend Details
Performance Map
Mutual fund Investment
Mutual fund Share Holding
Mutual Fund Search Category Rankings
Widgets
Stock Widgets
Watchlist
Heatmap
Mutual Fund Widgets
Watchlist
Calculators
EMI Calculator
SIP Calculator
SWP Calculator
GST Calculator
FD Calculator
RD Calculator
Wealth
World
Tips
Intraday Tips
Market Outlook
Stock Tips
Commodity Tips
Currency Tips
Reports
Short Term Investment Opportunities
Long Term Investment Opportunities
Sector Analysis
Commodity Reports
Currency Reports
Mutual Fund Analysis
Podcast
Videos
Videos Category
Business Videos
Budget Videos
News And Politics
Entertainment Videos
Sports Videos
Lifestyle And Fashion Videos
Global News Videos
Calculators
EMI Calculator
SIP Calculator
SWP Calculator
GST Calculator
FD Calculator
RD Calculator
More
Budget 2024
Astrology
Women
Politics
Entertainment
Car&Bike
Gadgets
Lifestyle
Sports
Health
Fashion
Diwali Reports
Diwali Expert Reports
News
Astrology
Beyond Market Car
Beyond Market Entertainment
Beyond Market Fashion
Beyond Market Gadgets
Beyond Market Health
Beyond Market India
Beyond Market Life Style
Beyond Market Sports
Broking Firm Views
Broking Firm Views - Long Term Report
Broking Firm Views - Sector Report
Broking Firm Views - Short Term Report
Budget 2024 Sector Reports
Budget Bites
Budget Economic Servey
Budget Expert Views
Budget Industry
Budget News
Budget Wishlist
Commodities
Commodities Reports
Commodity Top News
Company News
Company Result
Currency News
Currency Report
Currency Top News
Diwali Expert Views
Diwali Market Outlook
Diwali Report
Diwali Technical Report
Economy News
Expert View Institution
Expert Views
Industry News
IPO Analysis
IPO More News
IPO Reports
IPO Top News
Market Outlook
Mutual Fund Analysis
Mutual Fund Expert Views
Mutual Fund More News
Mutual Fund Top News
Podcast - Market Ki Awaaz
Special Event Expert Views
Special Event Reports
Startup
Startup Expections
Startup Speak
Stock Market
Stock On The Move
Top News
Top Stories
Videos
Videos Business
Videos Entertainment
Videos Global News
Videos Lifestyle And Fashion
Videos News And Politics
Videos Sports
Wealth
Women
World Market More News
World Top News
Search
Investors have become cautious against earnings wonders created by one product, as seen in the case of Divi’s and Laurus. PI’s dependence on pyroxasulfone is, thus, increasingly under the spotlight. However, we think the comparison is misplaced. We believe that the sun has not yet set on PI’s pyroxasulfone given i) PI’s pyroxasulfone is a case of structural growth whereas Divi’s and Laurus’ molecules were opportunistic, and ii) pyroxasulfone’s usage i...
Buy PI Industries Ltd For Target Rs. 3,575 - JM Financial
The company reported standalone net profit of Rs 252.10 crore for the quarter ended June 30, 2022 as compared to Rs 183.90 crore in the same period last year, registering a year-on-year growth of 37.09 per cent. Net revenue of the company rose substantially by 35.28 per cent at Rs 1,497.10 crore in April-June quarter of this fiscal as against Rs 1,106.70 crore in the corresponding period last year. During April-June quarter, operating expenses increased by 34.57 per cent to Rs 1,159.70 cro...
PI Industries Ltd. Q1 net profit up 37.09% at Rs 252.10 cr
PI Industries is currently trading at Rs. 2605.30, up by 82.45 points or 3.27% from its previous closing of Rs. 2522.85 on the BSE. The scrip opened at Rs. 2550.50 and has touched a high and low of Rs. 2640.00 and Rs. 2548.95 respectively. So far 11555 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 3533.30 on 14-Sep-2021 and a 52 week low of Rs. 2334.35 on 27-Jan-2022. Last one week high and low of the scrip st...
PI Industries shines on reporting 14% rise in Q4 consolidated net profit
PI Industries Ltd. Stock is trading in higher top higher bottom formation within an upward sloping channel formation marked with (black lines). Price has recently taken support on lower bank of the channel formation as well as on 100EMA and currently trading outside of the downward sloping consolidation market with (red lines) Relative strength index (RSI) is trading above 50 level which gives some signs of momentum development in price. Recommendation is to buy at current market pri...
Buy PI Industries Ltd For Target Rs. 3900- Monarch Networth
CSM pipeline remains strong; maintain BUY We believe PI’s CSM molecules pipeline is likely to offer a big market opportunity, on top of its existing portfolio. We understand that PI has recently been granted registration by CIBRC to manufacture several patented molecules. One of these molecules has been jointly developed by IsAgro and FMC. This molecule provides PI long-term revenue growth visibility with peak estimated annual sales of USD 200-250mn (for PI) and patent validity beyon...
Buy PI Industries Ltd For Target Rs.3,460 - JM Financial Services
PI Industries is currently trading at Rs. 2610.00, up by 58.70 points or 2.30% from its previous closing of Rs. 2551.30 on the BSE. The scrip opened at Rs. 2556.00 and has touched a high and low of Rs. 2642.20 and Rs. 2546.90 respectively. So far 25434 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 3533.30 on 14-Sep-2021 and a 52 week low of Rs. 2104.70 on 19-Mar-2021. Last one week high and low of the scrip st...
PI Industries shines on reporting 14% rise in Q3 consolidated net profit
PI Industries is currently trading at Rs. 3289.05, up by 27.90 points or 0.86% from its previous closing of Rs. 3261.15 on the BSE. The scrip opened at Rs. 3265.25 and has touched a high and low of Rs. 3315.35 and Rs. 3253.75 respectively. So far 3034 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 3533.30 on 14-Sep-2021 and a 52 week low of Rs. 1982.45 on 02-Feb-2021. Last one week high and low of the scrip sto...
PI Industries gains on executing two joint venture agreements
CSM segment going from strength to strength! PI’s FY21 Annual Report highlights its intention to build multiple growth engines and take PI to the next level in the global arena, with more substantive participation in the Life Sciences domain. Here are the key insights Pace of commercialization of new molecules increased * Custom Synthesis and Manufacturing (CSM) saw strong growth of 35% YoY (to INR33.2b) in FY21, driven by volume growth in existing products ...
Buy PI Industries Ltd For Target Rs.3,720 - Motilal Oswal
CSM segment going from strength to strength! * PI’s FY21 Annual Report highlights its intention to build multiple growth engines and take PI to the next level in the global arena, with more substantive participation in the Life Sciences domain. Here are the key insights: Pace of commercialization of new molecules increased * Custom Synthesis and Manufacturing (CSM) saw strong growth of 35% YoY (to INR33.2b) in FY21, driven by volume growth in existing products and the commercia...
Buy PI Industries Ltd For Target Rs.3,720 - Motilal Oswal
Broadening its horizon with API acquisition Earning below estimates, but strong show on high base * PI Industries (PI)’s operating performance during the quarter was impacted by one-time expenses pertaining to (i) COVID management, (ii) consulting fees, and (iii) other costs related to various strategic projects. Thus, despite this, the company reported EBITDA growth of 9% on the high base of last year. * PI acquired the Active Pharma Ingredient (API) business division of lnd Swi...
Buy PI Industries Ltd For Target Rs.3,720 - Motilal Oswal
Healthy performance; Outlook promising PI Industries manufactures plant protection & specialty plant nutrient products and solutions under its agri-inputs business. It is also one of India’s leading custom synthesis (CSM) companies engaged in providing contract research and contract manufacturing services to global innovators. * Standalone revenue grew 14.3% YoY to Rs. 1,107cr, owing to strong volumes resulting in solid export growth (+31.0% YoY), while domestic remained subdu...
Mid Cap - Buy PI Industries Ltd For Target Rs. 3,640 - Geojit Financial
Next growth phase to emanate from pharma… About the stock: Incorporated in 1947, PI Industries focuses on complex chemistry solutions in agri and pharma sciences. * The company maintains a strong research presence through its R&D facility in Udaipur, where it has a dedicated team of over 300 scientists * The revenues of the company can be subdivided into custom synthesis manufacturing (CSM) and domestic formulation business with the former contributing ~73% to overall reve...
Buy PI Industries Ltd For Target Rs. 3855 - ICICI Direct
Derivative Ideas PIIND FUTS added around 7% in open interest as LONG buildup was seen in it. Current chart pattern also indicates further up move in its price. We suggest buying in PIIND in cash as per below levels. Strategy:- BUY PIIND BETWEEN 3005-3010 STOPLOSS 2960 TARGET 3100. To Read Complete Report & Disclaimer Click Here Please refer disclaimer http://ex.religareonline.com/disclaimer SEBI Registration number is INZ000174330  ...
Buy PI Industries Ltd Target Rs. 3100 - Religare Broking
Temporary blip, but story intact In line revenue; EBITDA and PAT below our estimate due to lower GM * PI reported lower than expected numbers in 4QFY21 due to lower gross margin, impacted temporarily by: i) product mix changes, ii) consolidation of Isagro, which is relatively lower margin business, iii) MEIS impact, and iv) ramping up of new plants which impacted yields. * We maintain our FY22E/FY23E estimate. We value the stock at 35x FY23E EPS to arrive at a TP of INR2,945. Maintai...
Buy PI Industries Ltd For Target Rs.2,945 - Motilal Oswal
Next growth phase to emanate from pharma venture PI Industries reported topline growth of 40% YoY to | 1197 crore against our estimate of | 1185 crore. Growth was led by the CSM business, up 47% YoY to | 1006 crore. Revenue from domestic agri input was up 11% YoY to | 191 crore, largely driven by Isagro (up 52% YoY). Revenue from domestic branded formulation fell 11% YoY to | 100 crore. Change in the product mix and removal of MEIS benefits affected gross margins, which was down 469 bps Yo...
Buy PI Industries Ltd For Target Rs. 3010 - ICICI Direct
In-line revenue; EBITDA and PAT below est. due to lower GM * Reported revenue was up 40% YoY to INR12b (est. INR11.9b) in 4QFY21. * EBITDA was up 22% YoY to INR2.3b (est. INR2.8b). * EBITDA margins contracted 280bp YoY to 19% (est. 23.9%) on gross margin contraction; gross margins came in at 42.1% (-470bp YoY), employees at 9.2% (-190bp), and other expenses at 14% (flat YoY). * Adj PAT grew 62% YoY to INR1,798m (est. INR2,172m), aided by higher other income (+550% YoY to...
Flash PI Industries Ltd For Target Rs. 2,741 - Motilal Oswal
The company reported standalone net profit of Rs 182.10 crore for the quarter ended March 31, 2021 as compared to Rs 98.30 crore in the same period last year, registering a year-on-year growth of 85.25 per cent. Net revenue of the company rose substantially by 41.16 per cent at Rs 1,122.90 crore in January-March quarter of this fiscal as against Rs 795.50 crore in the corresponding period last year. During January-March quarter, operating expenses increased by 42.64 per cent to Rs 893.90 c...
PI Industries Q4 net profit jumps 85.25% at Rs 182.10 cr
Consistent outperformance; pipeline remains strong * Q3FY21 revenue/EBITDA/PAT beat our expectations by 8%/13%/10% on the back of robust 40% growth in exports (8% above est.) and 26% growth in the domestic business (10% above est). PI’s revenue/EBITDA increased 37%/48% yoy to Rs11.6bn/Rs2.76bn. * Export order book stood constant qoq at USD1.5bn, implying new life-time high quarterly order wins of ~USD120mn (~USD82mn/USD108mn order wins in Q1/Q2FY21). We note that PI’s quarte...
Buy PI Industries Ltd For Target Rs. 2,500 - Emkay Global
Strong earnings growth momentum continues * PI Industries (PI) reported a strong 3QFY21 performance, led by a 40%/26% YoY growth in Custom Synthesis and Manufacturing (CSM)/Domestic business. EBITDA growth of 48% YoY (on a high base of last year) was on the back of gross margin expansion and operating leverage. * PI reported in line numbers in 3QFY21. We, thus, maintain our estimates for FY21E/FY22E/FY23E. We value the stock at 33x FY23E EPS to arrive at TP of INR2,659, implying 18% up...
Buy PI Industries Ltd For Target Rs.2,659 - Motilal Oswal
The company reported standalone net profit of Rs 195.70 crore for the quarter ended December 31, 2020 as compared to Rs 120.40 crore in the same period last year, registering a year-on-year growth of 62.54 per cent. Net revenue of the company rose substantially by 31.12 per cent at Rs 1,114.30 crore in October-December quarter of this fiscal as against Rs 849.80 crore in the corresponding period last year. During October-December quarter, operating expenses increased by 26.90 per cent to Rs 8...
PI Industries Q3 net profit jumps 62.54% at Rs 195.70 cr
Now Get InvestmentGuruIndia.com news on WhatsApp. Click Here To Know More Shares of agrochemical companies with higher exposure to overseas markets have done relatively better than those with less exposure in fiscal year 2019. This isn’t surprising given the challenges in the domestic agrochemicals market. “The industry has been impacted due to declining farmer income and low pest pressure. Inventory for the industry is ~20-30% higher than normal," Prabhudas Lilladher...
Why UPL, PI Industries scored over Rallis India, Dhanuka Agritech in FY19
Load More